You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: October 4, 2024

Claims for Patent: 5,212,176


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,212,176
Title: R(+)-terazosin
Abstract:R(+)-2-[4-[(tetrahydro-2-furanyl)carbonyl]-1-piperazinyl]-6,7-dimethoxy-4-q uinazolinamine hydrochloride or a pharmaceutically acceptable salt or hydratet hereof (terazosin), substantially free of the S(-)-enantiomer.
Inventor(s): Kyncl; John J. (Lake Forest, IL), Horrom; Bruce W. (Waukegan, IL)
Assignee: Abbott Laboratories (Abbott Park, IL)
Application Number:07/546,349
Patent Claims: 1. The compound having the name R(+)-2-(4-((tetrahydro-2-furanyl)carbonyl)piperazinyl)-6,7-dimethoxy-4-qui nazolinamine hydrochloride dihydrate having an optical rotation [.alpha.].sub.D.sup.28.5.degree. C. (C=1, water) of 23.9.degree. or greater.

2. A pharmaceutical composition comprising a therapeutically effective amount of the compound as defined by claim 1 in combination with a pharmaceutically acceptable carrier.

3. A method of treating hypertension in a mammal in need of such treatment comprising administering a therapeutically effective amount of of the compound as defined by claim 1.

4. A method of treating benign prostatic hyperplasia in a mammal in need of such treatment comprising administering a therapeutically effective amount of the compound as defined by claim 1.

5. A method of treating hyperinsulinemia in a mammal in need of such treatment comprising administering a therapeutically effective amount of the compound as defined by claim 1.

6. A method of treating congestive heart failure in a mammal in need of such treatment comprising administering a therapeutically effective amount of the compound as defined by claim 1.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.